← Open Payments lookup

RACHEL LAI: Open Payments

NPI 1205277753 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,515 in 62 payments from 13 companies in 2025. Trend: 2023 $2,636 · 2024 $2,937 · 2025 $1,515

Food & beverage: $1,515
CompanyPaymentsAmount
Bayer Healthcare Pharmaceuticals Inc.7$248
Actelion Pharmaceuticals US, Inc.8$241
United Therapeutics Corporation9$234
Abbott Laboratories3$232
AstraZeneca Pharmaceuticals LP6$114
Alnylam Pharmaceuticals Inc.4$109
Merck Sharp & Dohme LLC5$92
Novo Nordisk Inc3$73
SCPHARMACEUTICALS INC.3$52
CVRx, Inc.10$49

Products named: UPTRAVI, Kerendia, CARDIOMEMS, Tyvaso, WAINUA, AMVUTTRA, FUROSCIX, ONPATTRO.

Industry payments across TX — which companies pay providers there.